Welcome new additions to our senior leadership team Troels, Julia, Ilian and Kevin businesswire.com/news/home/2021…
MiNA Therapeutics
@MiNA_Tx
Pioneering the development of a new class of medicines that use small RNA to activate genes
27 Following 610 Followers 75 Posts
Latest posts 5
Honoured to be highlighted by @Forbes in the new wave of genomics powered healthcare companies forbes.com/sites/alisonco…
Excited to be partnering with @LillyPad to expand the potential of small activating RNA medicines across a range of therapeutic areas
New Today: We’re announcing a global research collaboration with @MiNA_Tx to develop new medicines using their saRNA technology platform. Read more: e.lilly/3tISGLeView quoted post on X
We are thrilled to join forces with @Servier to tackle neurological disorders. This partnership will combine our profound #saRNA technology expertise with Servier’s disease-specific insights to develop new therapies for patients. More here: businesswire.com/news/home/2021…
Delighted to announce £23m / $30m Series A financing to fuel the next stage of development of small activating RNA medicines businesswire.com/news/home/2020…£23-Million-Series-Financing